ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 176

Implementation of an Abbreviated Neuropsychology Screening Protocol for Patients Diagnosed with Childhood-onset Systemic Lupus Erythematosus

Camille Wilson1, Alana Leever 1, Jennifer Cass 1, Vidya Sivaraman 2 and Stacy Ardoin 1, 1Nationwide Children's Hospital, Columbus, 2Division of Rheumatology, Nationwide Children's Hospital, Bexley

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Assessment, neuropsychology, pediatrics, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Friday, May 1, 2020

Title: Poster Session 2

Session Type: ACR Abstract Session

Session Time: 5:00PM-6:00PM

Background/Purpose: Research has established that a large percentage of individuals diagnosed with childhood-onset systemic lupus erythematosus (cSLE) report cognitive dysfunction. Disease factors that can impact cognitive function in cSLE include inflammation, ischemia, and direct antibody effects on grey and white matter. Common cognitive domains affected include attention/executive functioning, memory, visual-spatial skills, language, and psychomotor speed. Identification of neurocognitive deficits by neuropsychological evaluation can help inform treatment recommendations and access to supports. A traditional full-day evaluation may not be practical nor an efficient use of resources for all patients with cSLE, whereas existing computerized screening measures take approximately 35-55 minutes to administer. Neurocognitive screening offers a practical method to quickly assess relevant cognitive domains and identify patients who may benefit from a comprehensive neuropsychological evaluation. The current study sought to explore feasibility of a neurocognitive screening protocol during a multidisciplinary cSLE clinic.

Methods: A brief neurocognitive screening battery was selected based on research findings and priorities of brief duration (10-15 minutes), usability for broad age range (≥8 years), and assessment of typically affected domains. Tools were administered by a neuropsychologist. A decision chart (see Figure 1) outlined the process for referring patients for half-day (3-hour) or full-day (6-hour) neuropsychological evaluation. Neurocognitive screening was routinely completed on consecutive patients in the context of a psychosocial consult visit during a multidisciplinary lupus clinic visit. Scaled and standard scores were transformed to z-scores to allow ease of comparison across subtests.

Results: Beginning in September 2018, 27 individuals diagnosed with cSLE (mean age 16.96 years; SD = 3.13) completed neurocognitive screening. Females comprised the majority of the sample (n = 22, 81.5%). The average time of consult visit with neurocognitive screening was 22.04 minutes (SD = 5.61). On screening measures, almost 50% of individuals performed at least one domain in the below average range, while approximately 25% of individuals performed in the below average range for greater than two neurocognitive domains. Eleven individuals (18.5%) were referred for a neuropsychological evaluation. Two families declined referrals as results were felt to be due to other psychosocial factors (for example, anxiety, not feeling well on the day of the screening).

Conclusion: The current study indicates that brief neurocognitive screening is feasible within a multidisciplinary lupus clinic. Brief neurocognitive screening may help identify individuals who are at higher risk for cognitive challenges. Results of screening indicate that 25-50% of individuals with cSLE are performing below age expectations and may warrant referral for a comprehensive evaluation. Future examination of other medical and psychosocial factors linked to neurocognitive challenges in c-SLE may help increase the efficiency of neurocognitive screening within this population.


Disclosure: C. Wilson, None; A. Leever, None; J. Cass, None; V. Sivaraman, None; S. Ardoin, None.

To cite this abstract in AMA style:

Wilson C, Leever A, Cass J, Sivaraman V, Ardoin S. Implementation of an Abbreviated Neuropsychology Screening Protocol for Patients Diagnosed with Childhood-onset Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/implementation-of-an-abbreviated-neuropsychology-screening-protocol-for-patients-diagnosed-with-childhood-onset-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/implementation-of-an-abbreviated-neuropsychology-screening-protocol-for-patients-diagnosed-with-childhood-onset-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology